chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Anxiety; Patient was already revaccinated with another booster dose of 0.25mL.; Expired dose given was booster dose on 3Nov2021; Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F):26 hours; This spontaneous case was reported by a nurse and describes the occurrence of ANXIETY (Anxiety), EXPIRED PRODUCT ADMINISTERED (Expired dose given was booster dose on 3Nov2021), PRODUCT STORAGE ERROR (Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F):26 hours) and EXTRA DOSE ADMINISTERED (Patient was already revaccinated with another booster dose of 0.25mL.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Nov-2021 at 3:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F):26 hours). On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose given was booster dose on 3Nov2021). On an unknown date, the patient experienced ANXIETY (Anxiety) and EXTRA DOSE ADMINISTERED (Patient was already revaccinated with another booster dose of 0.25mL.). On 03-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose given was booster dose on 3Nov2021) and PRODUCT STORAGE ERROR (Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F):26 hours) had resolved. At the time of the report, ANXIETY (Anxiety) outcome was unknown and EXTRA DOSE ADMINISTERED (Patient was already revaccinated with another booster dose of 0.25mL.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Dose was administered >12(US)/24(CA) hours post puncture. Vial was first punctured on 2nd Nov2021 at 12:45 pm. Patient was revaccinated with another booster dose of 0.25mL on an unknown date. No concomitant medication were given. No treatment information were provided.
Coughing, wheezing. Benadryl liquid (12.5 mg/5ml) 6.25 mg po at 4:45 pm; father is a physician, took child home to give jet neb treatment for wheezing, at 7:30 PM child was doing well, father stated "much better after breathing treatment".
Marked swelling and erythema at injection site. Significant pruritus at affected area surrounding injection site.
Excruciating headache for three days, fatigue for three days, not eating three days,
not received 2nd dose yet; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 12 months ago with batch number 4CN95 and expiry date 15 September 2023).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: not received 2nd dose yet).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 05-SEP-2023 The reporter reported that he/she had a patient in office who received the first Shingrex dose 12 months ago.  The reporter wanted to know if he still eligible for a booster or he need to restart series. Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow-up.
Patient said she experienced facial swelling 3 hours after the Flu shot around the left side by the eye area. It has gone down since then. There was no swelling at the site of the injection. She feels ok otherwise. Just wanted to notify us.
Moderna Bivalent Covid Vaccine was given one day after its expiration date of 6/18/2023. Pt experienced no symptoms or signs of adverse reaction.
Narrative:  Patient experienced cardiac arrest with PEA and a witnessed collapse upon arrival to the emergency department on 1/24/21. Patient received his first dose of the COVID vaccine on 01/15/2021and felt poorly thereafter. He was describing shortness of breath to his wife and requiring 5L of O2 at home to maintain saturations in 80s, while he usually was on 3L to maintain saturations in the mid 90s. He had been oriented but more fatigued than normal and described bilateral shoulder pain (which was not new for him) as well as indigestion. Took Tylenol with some relief. He had decreased PO intake and less appetite. The patient's wife encouraged him to come to the hospital daily for a week prior to admission, but the patient did not want to because he felt his side effects were secondary to the vaccine. Symptoms:RespDepression, Palpitations, Syncope & cardiac arrest Treatment: EPINEPHRINE 1 MG ONCE 3 rounds given ,CALCIUM CHLORIDE 1000 MG ONCE
24 hours after receiving 2nd Moderna vaccine, became feverish (103.5) and very weak.  Was unable to stand and ambulate.  Tried to rise from chair at home and fell, requiring ambulance transfer to local ER
This spontaneous report as received from a nurse refers to a 12 month old patient of unknown gender. Pertinent medical history and drug reactions/allergies were not reported. On 12-FEB-2016 during an office visit, the patient might have been vaccinated with a dose of GARDASIL 9 lot # L013429, expiration date: 21-JUL-2017 (dose and route were not reported) inadvertently (Inappropriate schedule of drug administration). Concomitant drug was not reported. The reporter stated that it could not be determined if the patient did indeed receive the vaccination or if it was a documentation error. No adverse effects were reported. Additional information has been requested.
Around 12 hours after my first Pfizer dose in the L arm i developed tingling on L side of face, fullness and decreased sensation. Additionally tingling and sense of burning and heat in L arm. I knew it was a neurological side effect so was not concerned about heart issues but was deathly scared I would get Bells Palsy or some kind of MS like condition. Thankfully this has mostly gone away after three weeks. There is nothing I want more than to be fully vaccinated but quite frankly I am too scared to and will not get dose two.  I have been fully vaccinated against other illness-even got the yellow fever vaccine when I was supposed to travel overseas and this is the FIRST time I had such bad side effects.
p/vax pt exp swollen sore lt arm; advised comfort measures; cold compress; elevation when resting; tylenol; activity w/arm;
Fever, chills, body aches, headache, nausea. No treatment needed but rest, fluids, and light meals. Symptoms began to subside by afternoon, and fully resolved by the next day.
Nausea, 101 fever, headache, body ache, sensitivity to light, insomnia
Pt recvd 3 doses of Engerix-B & did nt seroconvert; Booster doses were administered;
2 vaccine shots and now I have them again/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was self reported by th patient. The age at vaccination was not reported. The patient had 2 vaccine shots and had shingles again.  The reporter stated that, it was no fun. This case was considered as suspected vaccination failure as details regarding the laboratory test confirming shingles and time to onset for shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with M-M-R II (lot #, route and dose were unknown). The patient had positive titer for measles and rubuella on an unknown date. The outcome of event was unknown. This is one of several reports received from the same source. Additional information is not expected.
Patient was accidentally given Shingrix when she should have only gotten Moderna. No treatment has been required. Patient had no adverse reaction during waiting period after vaccine administration.
redness lt arm @ inj site & tender to touch;redness & swelling moved down to elbow;very painful;lt elbow still swollen & warm to touch;
Afternoon after receiving vaccination (Saturday), patient had pain at the injection site as expected, and as the day went on the pain got worse with a some redness and swelling at the injection site.  Patient applied ice and heat to the site which she has not had to do in the past with any other vaccines.  The following day (Sunday), the pain and swelling got worse.  The swelling started moving up over the patient's shoulder.  The patient had an episode of her arm locking, and she was not able to move it for 10-15 minutes.  She was able to get it to move about a half hour later, and it remained sore throughout the day.  Patient continued to move arm throughout the day so it would not lock and rotated heat and ice compresses.  The next day (Monday) upon waking up in the morning morning, the swelling had extended down to patient's hand and closer to patient's neck.  She went to her PCP and they said there was nothing they could do to contact the vaccine administrators and see if they had any solutions and to continue to apply ice and heat and go to ER if any fever or SOB occurs.
Patient was given a Moderna vaccine as a 2nd dose, but their first dose was Pfizer on 9/2/2021
Patient received second dose of Moderna COVID vaccine on 2/4/21 at 9:00am. Patient took blood sugar on 2/5/21 at 9:00am and blood sugar was elevated at 219. Patient reports normal blood sugar is around 110. Patient reports having a headache, chills, and muscle aches that night of administration. Patient continued to have a headache 24 hours after vaccine so she took her blood sugar and  it was elevated. Client reports taking normal dose of glipuride  (1mg) and farxgia to lower blood sugar. Patient retook blood sugar 3.5 hours later, 181. Patient retook blood sugar 4 hours after that and it was 161. Client reports her blood sugar is still currently evaluated and is taking her additional dose of glipuride.
Vaso Vagal  At 13:30 BP 168/98 HR 119 O2Sat 99  Skin Signs: Warm and Dry, Other: Pale Resp: Breath sound clear bilaterally  At 13:34 HR 105 At 13:36 BP 150/90 HR 89 O2Sat 99 At 13:40 BP 152/88 HR 82 O2Sat 95 Resp 12 At 14:02 BP 132/82 Vitals taken at 13:30. Continued monitoring.  A/Ox4, Pt states no previous vaso vagal  Disposition: Home by Self
Tingling in extremities followed by weakness and inability to walk.  Hospitalized and received plasmapheresis for GBS. D/c to nursing home for rehab therapy.
died / deathly ill; This case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a 58-year-old male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Concurrent medical conditions included autoimmune disorder (compromised immune system).   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. In December 2020, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced death (serious criteria death and GSK medically significant). On an unknown date, the outcome of the death was fatal. The patient died in December 2020. The reported cause of death was unknown cause of death.   It was unknown if the reporter considered the death to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were received as follows: The age at vaccination was not reported. The patient died in December of 2019. He got deathly ill right after he got a flu shot. He had a compromised immune system so the reporter wanted to know why did they give him the shot.; Reported Cause(s) of Death: Unknown cause of death
lt thigh pain keeps lt leg stiff w/walking for about 1 wk;fever start 10JUL96;t102;
For three weeks, I experienced racing heart, dizziness, nausea, shortness of breath, headaches,  trouble focusing and difficulties sleeping. I experienced the same symptoms with the first dose, but with lesser intensity (symptoms went away within a week or so). My primary care suggested over-the-counter medication to help with sleep and to go to urgent care/ER if my heartrate became unbearable. I stayed home and took life tasks extremely slow.
5/7/21 started having vertigo   4/28/21 started to wean off of citalopram onto wellbutrin 5/5/21 started on cephalexin for UTI 6/23/21 started working up vertigo as it worsened eventually saw ENT and audiologist and diagnosed with vestibular neuritis
No ADR, timing ERROR, 2nd dose given 66 days after 1st Narrative: Timing ERROR only
Post vax pt developed low grade fever and an injection site reaction characterized by redness and swelling. The pt recovered. This is 1 of 4 patients from this facility who experienced this event following receipt of injection.
This spontaneous report as received from healthcare worker refers to an unspecified number of patients of unknown age. On 25-FEB-2015 the patients was vaccinated with VAQTA (dose, lot number, was unkonwn), intramuscularly which was improperly stored. No adverse effects were reported. The outcome of the event was unknown. This is one of the several reports received from the same reporter. No additional information was reported. Additional information has been requested.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Nov2022 at 12:00 as dose 4 (booster), single (Lot number: GH9694) at the age of 65 years, in right arm for COVID-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid. Additional information: The patient has no known allergies.
3 days post vaccination - 3.5 in x 4 in area flat erythematous. Warm. No tenderness. No swelling. No drainage. Area marked and patient started on treatment for cellulitis. Patient showed no other signs/symptoms.
Sick for couple days; Vey bad fever of 100.4°F; Very bad headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for couple days), PYREXIA (Vey bad fever of 100.4°F) and HEADACHE (Very bad headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No medical history provided by repoter.  Concomitant products included PREDNISONE and LEFLUNOMIDE for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick for couple days), PYREXIA (Vey bad fever of 100.4°F) and HEADACHE (Very bad headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (Sick for couple days), PYREXIA (Vey bad fever of 100.4°F) and HEADACHE (Very bad headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.4 (High) 100.4°F.         This case was linked to MOD-2021-327066 (Patient Link).
Soreness at sight of injection followed by chills, fever, muscle and joint aches throughout body.  Shakes and intermittent hot flashes and nausea accompanied by stuffy head, inability to concentrate.  Excessive yawning and need to stretch legs frequently.  These symptoms still present at 8:15 p.m. on 4/8/21, with exception of yawning.
On 01/04/2023, I started experiencing symptoms like I was experiencing a bad flu. I tested at home for Covid-19, and the test came back negative. I tested positive for Covid-19 on 01/05/2023. I contacted PCP to see if they could prescribe anti-viral. My wife had also tested positive for COVID-19. As of 01/16/2023, I am still testing positive and I have completed the anti-viral treatment. I am starting to feel better, though I did feel bad yesterday. Some days, I feel like I don't have any energy.
My headache and neck ache started the following day after the vaccine, and continue now at 11 days out.  Mild headache, stiff neck
Modern COVID-19 vaccine  Fever to 102.4 with shaking chills, joint aches, extreme fatigue for 36 hrs
8 hours post injection: fever (101 tmax), chills, headache, injection site soreness.  Fever, chills, headache resolved 36 hours post injection.  Approx 90 hours post injection wheal lesions on R arm appear (not on injection site) ,red/warm to touch, swelling to injection site, decreased ROM to RUE.
The patient is not experiencing any symptoms. No additional adverse effect reported; The patient was administered the live VARIVAX vaccine less than 28 days after she received the live influenza vaccine, FLUMIST; This spontaneous report was received from a nurse referring to a female patient of unknown age. The patient pertinent medical history, concurrent conditions, drug reactions or allergies were not reported.   On 26-AUG-2019, The patient was vaccinated with first dose of varicella virus vaccine live (oka/merck)(VARIVAX), subcutaneous for prophylaxis (strength, dose, frequency, lot number and expiration date were not provided).   On 27-NOV-2019, the patient was vaccinated with second dose of varicella virus vaccine live (oka/merck)(VARIVAX), subcutaneous for prophylaxis (strength, dose, frequency were not provided) (Lot number S005085 is an invalid lot number for varicella virus vaccine live (oka/merck)(VARIVAX), expiration date 19-FEB-2021), less than 28 days after received the live influenza vaccine, influenza virus 3v reassortant vaccine live intranasal (cold adapted ann arbor master strain) (FLUMIST) who was administered on 05-NOV-2019 (inappropriate schedule of product administration). The patient not experienced any symptoms, no additional adverse effect reported.
Headache Arm tenderness Knot in arm Itchy at injection site Congestion  Sore throat Fatigue
Patient report redness and swelling at the injection site. She also reports pain from her shoulder to her elbow and a rash that formed on 05/24/2022. As of 05/26/2022 patient reports she still has pain in the arm but the other symptoms have improved.
Been itching all over 5 mins to receiving vaccine. Sun red in color. Hives noted on trunk. Scratching all over. Began c/o throat felt funny. Benadryl 2 dose given oral. EPI. 3ml Lisicool given Duson 5g. x 2 Prelone 35 mg po given, 911 called Transported  wakened ?Raleigh dyemJ.
4 funerals of people who have died 3 to four days after getting the COVID-19 vaccine; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, Expiry date: not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Caller stated that he was been doing some research on the amount of people who have died from taking the COVID-19 vaccine and what adverse events they have had after receiving the vaccine. He stated that he had personally gone to 4 funerals of people who have died 3 to four days after getting the COVID-19 vaccine, but stated he did not knew whether they were moderna or Pfizer or Johnson and Johnson and he did not knew one person who had died from the actual virus. He just wanted information. Caller wanted to know that the Pfizer COVID-19 vaccine was fully approved if he took the vaccine and had adverse side effects from it who was going to pay for his bills. The patient died on an unspecified date. It was not reported if an autopsy was performed and cause of death was not reported.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: 4 funerals of people who have died 3 to four days after getting the COVID-19 vaccine
The morning before my second Moderna vaccine I took a pregnancy test and it was inconclusive so I figured I wasn't pregnant and got my second vaccine (1/26/21). I missed my period and took another pregnancy test on 1/30/21 and it was positive. I went to my first ultrasound on 3/2/21 when I should have been around 8 or 9 weeks and the baby was measuring small but it had a heart beat that was in a normal range. A week later on 3/9/21 I started spotting and I called my doctor and they told me to let them know if it got worse. I went to work but by the end of my shift the bleeding had got worse and my doctor made me go to the ER so I could have another ultrasound. The ultra sound showed the baby still had a heart rate but it was low. I stayed home from work the next day to take it easy and I ended up having a miscarrage that night 3/10/21. I had a follow up ultrasound on 3/11/21 that proved it. I wasn't planning on reporting this because really anything could have caused it but I signed up for the vaccine app when I got my vaccines and answered the follow up questions. Someone called me because of how I answered my question and she recommended that I report it.
patient had been given only the adjuvant portion; patient had been given only the adjuvant portion; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 7C4B3, expiry date 14th November 2022) for prophylaxis.   On 20th August 2021, the patient received Shingrix. On 20th August 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The patient had been given only the adjuvant portion of the Shingrix vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.